Electronic Journal of Biotechnology (Jul 2019)
Antiproliferative activity of biomass extract from Pseudomonas cedrina
Abstract
Background: The study of plant-associated microorganisms is very important in the discovery and development of bioactive compounds. Pseudomonas is a diverse genus of Gammaproteobacteria comprising more than 60 species capable of establishing themselves in many habitats, which include leaves and stems of many plants. There are reports of metabolites with diverse biological activity obtained from bacteria of this genus, and some of the metabolites have shown cytotoxic activity against cancer cell lines.Because of the high incidence of cancer, research in recent years has focused on obtaining new sources of active compounds that exhibit interesting pharmacodynamic and pharmacokinetic properties that lead to the development of new therapeutic agents. Results: A bacterial strain was isolated from tumors located in the stem of Pinus patula, and it was identified as Pseudomonas cedrina. Extracts from biomass and broth of P. cedrina were obtained with chloroform:methanol (1:1). Only biomass extracts exhibited antiproliferative activity against human tumor cell lines of cervix (HeLa), lung (A-549), and breast (HBL-100). In addition, a biomass extract from P. cedrina was fractioned by silica gel column chromatography and two diketopiperazines were isolated: cyclo-(l-Prolyl-l-Valine) and cyclo-(l-Leucyl-l-Proline). Conclusions: This is the first report on the association of P. cedrina with the stems of P. patula in Mexico and the antiproliferative activity of extracts from this species of bacteria against human solid tumor cell lines.How to cite: Sánchez-Tafolla L, Padrón JM, Mendoza G, et al. Antiproliferative activity of biomass extract from Pseudomonas cedrina. Electron J Biotechnol 2019;40. https://doi.org/10.1016/j.ejbt.2019.03.010. Keywords: Antiproliferative activity, Bioactive compounds, Cancer, Diketopiperazines, Mexico, Pinus patula, Plant-associated bacteria, Plant-associated microorganisms, Pseudomonas cedrina, Therapeutic agents